In this work, we aimed to determine Souvenaid’s efficacy and safety in patients with mild AD in real clinical practice, and to elucidate a potential synergistic effect of combined therapy with Souvenaid plus AChE inhibitors on this population. The gene discussed is ACHE; the disease is Alzheimer disease.